Any cardiovascular protection from colchicine in heart attack survivors seemed to be debunked with a better-powered ...

Colchicine is an effective treatment for most pediatric patients with complex aphthous stomatitis (CAS), results from a small retrospective study showed. Ananya Shah "Complex aphthous stomatitis ...

The presence of an operational classification of drug interactions (ORCA) class 3 or 4 drug-drug interactions (DDIs) did not increase the risk for colchicine-related gastrointestinal adverse ...

IN a previous report 1 I described my experience with colchicine in 2 patients with sarcoid arthritis. In the first, each of four acute bouts of joint inflammation was abruptly terminated in less ...

Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. In this multicenter trial with a 2-by-2 ...

The FDA approved colchicine (Lodoco) for cardiovascular prevention in adults with established atherosclerotic disease or multiple risk factors, making it the first anti-inflammatory medicine with ...

Colchicine is effective in many inflammatory and fibrotic conditions, but it is not currently recommended for treatment of osteoarthritis. Its long-term effects have also not been assessed.

Colchicine was licensed for use by the FDA in 1961, predating the regulator’s authority to oversee its safety. In 2007, when the Unapproved Drug Initiative required some marketed treatments to ...

A 0.5 mg dose of colchicine has been approved for use in high-risk patients who have inflammatory risk. The dose is the same as that used in two successful trials, but it had not been available in ...

Due to a policy decision in 2010 by the U.S. Food and Drug Administration (FDA), the price of a prescription for the therapeutic gout drug colchicine increased nearly 16-fold from $11.25 in 2009 ...

Due to a policy decision in 2010 by the U.S. Food and Drug Administration (FDA), the price of a prescription for the therapeutic gout drug colchicine increased nearly 16-fold from $11.25 in 2009 ...